Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
Kwon, Brian-Yong S. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
10606632
ABSTRACT:
The present invention relates to a pharmaceutical composition comprising an insulin sensitizer and a diuretic which can prevent or treat side effects such as edema, cardiac enlargement, body fluid retension or hydrothorax caused by administration of an insulin sensitizer.
REFERENCES:
patent: 4687777 (1987-08-01), Meguro et al.
patent: 4897393 (1990-01-01), Iijima et al.
patent: 5002953 (1991-03-01), Hindley
patent: 5457109 (1995-10-01), Antonucci et al.
patent: 5594016 (1997-01-01), Ueno et al.
patent: 5643931 (1997-07-01), Niigata et al.
patent: 5693651 (1997-12-01), Nomura et al.
patent: 5728720 (1998-03-01), Shinkai
patent: 5886014 (1999-03-01), Fujita et al.
patent: 6030990 (2000-02-01), Maeda et al.
patent: 6103907 (2000-08-01), Yanagisawa et al.
patent: 6528525 (2003-03-01), Yanagisawa et al.
patent: 6596751 (2003-07-01), Fujita et al.
patent: 2002/0013334 (2002-01-01), Robl et al.
patent: 2003/0073729 (2003-04-01), Kitahara et al.
patent: 0 745 600 (1996-12-01), None
patent: 745600 (1996-12-01), None
patent: 0 861 831 (1998-09-01), None
patent: 1 180 519 (2002-02-01), None
patent: WO 97/11055 (1997-03-01), None
patent: WO 97/31907 (1997-09-01), None
patent: WO 99/19313 (1999-04-01), None
patent: WO 99/62872 (1999-12-01), None
patent: WO 00/61127 (2000-10-01), None
patent: WO 01/17513 (2001-03-01), None
patent: WO 01/21602 (2001-03-01), None
patent: WO 01/47509 (2001-07-01), None
Mizukami J, Taniguchi T., “The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP”, Biochem Biophys Res Commun. Nov. 7, 1997;240(1):61-4.
Fukui Y, et. al., “A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice”, Diabetes. May 2000;49(5):759-67.
Devasthale et. al., “Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with effacious glucose and lipid-lowering activities”, J Med Chem. Mar. 24, 2005;48(6):2248-50.
Hosokawa, et al., “Troglitazone Inhibits Bicarbonate Secretion in Rat and Human Duodenum1”,Journal of Pharmacology and Experimental Therapeutics, The American Society for Pharmacology and Experimental Therapeutics, Sep. 1999, pp. 1080-1084, XP008002057, ISSN: 0022-3565, vol. 3, No. 290, USA.
Dagogo-Jack, et al., “Pathophysiology of Type 2 Diabetes and Modes of Action of Therapeutic Interventions”,Archives of Internal Medicine, American Medical Association, Sep. 8, 1997, pp. 1802-1817, XP000872498, ISSN: 0003-9926 vol. 157, No. 16, Chicago, IL.
Gilbert et al., “Drug Administration in Patients with Diabetes Mellitus-Safety Considerations”,Drug Safety, (1998), pp. 441-455, vol. 18, No. 6, XP001041098, ISSN: 0114-5916, Adis Press, Auckland NZ.
Hosokawa, et al., “Troglitazone Inhibits Bicarbonate Secretion in Rat and Human Duodenum1”, Journal of Pharmacology and Experimental Therapeutics, The American Society for Pharmacology and Experimental Therapeutics, Sep. 1999, pp. 1080-1084, XP008002057, ISSN: 0022-3565, vol. 3, No. 290, USA.
Dagogo-Jack, et al., “Pathophysiology of Type 2 Diabetes and Modes of Action of Therapeutic Interventions”, Archives of Internal Medicine, American Medical Association, Sep. 8, 1997, pp. 1802-1817, XP000872498, ISSN: 0003-9926 vol. 157, No. 16, Chicago, IL
Gilbert et al., “Drug Administration in Patients with Diabetes Mellitus-Safety Considerations” Drug Safety, (1998), pp. 441-455, vol. 18, No. 6, XP001041098, ISSN: 0114-5916, Adis Press, Auckland NZ.
Araki Kazushi
Kanda Shoichi
Takaoka Masaya
Frishauf Holtz Goodman & Chick P.C.
Kwon Brian-Yong S.
Sankyo Company Limited
Zhang Nancy
LandOfFree
Medicinal compositions containing diuretic and insulin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal compositions containing diuretic and insulin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal compositions containing diuretic and insulin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772211